keyword
https://read.qxmd.com/read/38646776/pharmacokinetic-control-of-orally-dosed-cyclosporine-a-with-mucosal-drug-delivery-system
#1
JOURNAL ARTICLE
Kohei Yamada, Kurt D Ristroph, Yuuki Kaneko, Hoang D Lu, Robert K Prud'homme, Hideyuki Sato, Satomi Onoue
This study aimed to control the oral absorption of cyclosporine A (CsA) with the use of a mucosal drug delivery system (mDDS). Mucopenetrating nanocarriers (MP/NCs) and mucoadhesive nanocarriers (MA/NCs) were prepared by flash nanoprecipitation employing polystyrene-block-poly(ethylene glycol) and polystyrene-block-poly(N,N-dimethyl aminoethyl methacrylate), respectively. Their particle distribution in the rat gastrointestinal tract were visualized by fluorescent imaging. Plasma concentrations were monitored after oral administration of CsA-loaded MP/NCs (MP/CsA) and MA/NCs (MA/CsA) to rats...
April 22, 2024: Biopharmaceutics & Drug Disposition
https://read.qxmd.com/read/38646469/incidence-of-drug-related-adverse-events-related-to-the-use-of-high-alert-drugs-a-systematic-review-of-randomized-controlled-trials
#2
REVIEW
Michelle Santos Menezes, Grace Anne Azevedo Doria, Fernanda Valença-Feitosa, Sylmara Nayara Pereira, Carina Carvalho Silvestre, Alfredo Dias de Oliveira Filho, Iza Maria Fraga Lobo, Lucindo José Quintans-Júnior
BACKGROUND: High-alert medication (HAM) is more predictable to cause significant harm to the patient, even when used as intended. The damage related to the HAM lead not only suffering to the patient, but also raise the additional costs associated with care. OBJECTIVE: Evaluate the incidence of drug-related adverse events related to the use of high-alert medications. METHODS: It was conducted an active search for information through COCHRANE databases, LILACS, SciELO, SCOPUS, PubMed/MEDLINE and WEB OF SCIENCE...
June 2024: Explor Res Clin Soc Pharm
https://read.qxmd.com/read/38646109/vitiligo-in-a-patient-receiving-adalimumab-for-idiopathic-uveitis
#3
JOURNAL ARTICLE
Mehmet Fatih Kağan Değirmenci, Fatime Nilüfer Yalçındağ
In recent years, adalimumab has been increasingly used in the chronic treatment of non-infectious uveitis. This case report aimed to describe a drug-induced adverse event in a 34-year-old man who presented with blurred vision and floaters in the right eye and was being treated for intermediate uveitis. The patient had started topical treatment with a diagnosis of uveitis at another center. Best corrected visual acuity at presentation was 0.8 (decimal) in the right eye and 1.0 in the left eye. On examination, the anterior chamber in the right eye was clear, with anterior vitreous cells and mild haze, and snow banking and vitreous opacities in the inferior periphery...
April 19, 2024: Turkish Journal of Ophthalmology
https://read.qxmd.com/read/38645965/vasoproliferative-tumor-secondary-to-sarcoidosis-associated-intermediate-uveitis
#4
JOURNAL ARTICLE
Sara Abdel Jalil, Tareq Jaouni, Radgonde Amer
We report the visual and clinical outcomes of a middle-aged woman who presented with exudative retinal detachment (ERD) secondary to a vasoproliferative tumor (VPT) in an eye with sarcoidosis-associated intermediate uveitis. A 55-year-old woman previously diagnosed with sarcoidosis presented with decreased vision in the left eye (LE). Visual acuity in the LE was counting fingers. She had active vitritis, and a peripheral retinal vascular mass was noted in the superotemporal periphery. The mass was associated with ERD involving the posterior pole...
April 19, 2024: Turkish Journal of Ophthalmology
https://read.qxmd.com/read/38645919/rituximab-mycophenolate-combination-therapy-in-children-with-calcineurin-inhibitor-resistant-fsgs
#5
JOURNAL ARTICLE
Saumil Gaur, Partha P Paul, Mounika Motamarri
INTRODUCTION: There is a paucity of data and therapeutic options nationally and internationally on calcineurin inhibitor (CNI)-resistant forms of focal segmental glomerulosclerosis (FSGS) in children. CNI (tacrolimus or cyclosporine) are proven monotherapy in children with FSGS with a steroid-dependent (SD) or steroid-resistant (SR) course. We analyzed a novel therapeutic option in CNI-resistant FSGS by using the dual therapy of rituximab and mycophenolate to maintain remission. METHODS: This is a retrospective analysis of clinical, therapeutic profile, and treatment outcomes (sustained remission versus no remission) in subjects with CNI-resistant FSGS who received dual rituximab therapy along with mycophenolate as maintenance therapy for a minimum of 1 year...
2024: Indian Journal of Nephrology
https://read.qxmd.com/read/38639271/the-impact-of-spironolactone-co-administration-on-cyclosporin-initial-dosage-optimization-for-pediatric-refractory-nephrotic-syndrome
#6
JOURNAL ARTICLE
Huan-Huan Han, Min Rui, Yang Yang, Jia-Fang Cui, Xue-Ting Huang, Shi-Jia Zhang, Su-Mei He, Dong-Dong Wang, Xiao Chen
OBJECTIVES: Cyclosporin has been used for the treatment of pediatric refractory nephrotic syndrome (PRNS). However, the narrow therapeutic window and large pharmacokinetic variability make it difficult to individualize cyclosporin administration. Meanwhile, spironolactone has been reported to affect cyclosporin metabolism in PRNS patients. This study aims to explore the initial dosage optimization of cyclosporin in PRNS based on the impact of spironolactone co-administration. METHODS: Monte Carlo simulation based on a previously established cyclosporin population pharmacokinetic model for PRNS was used to design cyclosporin dosing regimen...
April 18, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38636613/alleviation-of-microcystin-leucine-arginine-induced-hepatotoxicity-an-updated-overview
#7
REVIEW
Habibeh Mashayekhi-Sardoo, Ramin Rezaee, Bamdad Riahi-Zanjani, Gholamreza Karimi
OBJECTIVES: Contamination of surface waters is a major health threat for all living creatures. Some types of blue-green algae that naturally occur in fresh water, are able to produce various toxins, like Microcystins (MCs). Microcystin-leucine arginine (MC-LR) produced by Microcystis aeruginosa is the most toxic and abundant isoforms of MCs, and it causes hepatotoxicity. The present article reviews preclinical experiments examined different treatments, including herbal derivatives, dietary supplements and drugs against MC-LR hepatotoxicity...
April 16, 2024: Toxicon: Official Journal of the International Society on Toxinology
https://read.qxmd.com/read/38632691/nanoceria-mediated-cyclosporin-a-delivery-for-dry-eye-disease-management-through-modulating-immune-epithelial-crosstalk
#8
JOURNAL ARTICLE
Wenyu Cui, Sheng Chen, Tianyi Hu, Tinglian Zhou, Chen Qiu, Luyang Jiang, Xiaoyu Cheng, Jian Ji, Ke Yao, Haijie Han
Dry eye disease (DED) affects a substantial worldwide population with increasing frequency. Current single-targeting DED management is severely hindered by the existence of an oxidative stress-inflammation vicious cycle and complicated intercellular crosstalk within the ocular microenvironment. Here, a nanozyme-based eye drop, namely nanoceria loading cyclosporin A (Cs@P/CeO2 ), is developed, which possesses long-term antioxidative and anti-inflammatory capacities due to its regenerative antioxidative activity and sustained release of cyclosporin A (CsA)...
April 17, 2024: ACS Nano
https://read.qxmd.com/read/38632138/comparison-of-old-and-new-systemic-treatments-for-moderate-to-severe-atopic-dermatitis
#9
REVIEW
Hyun J Yim, Tiffany Jean, Peck Y Ong
PURPOSE OF REVIEW: Historically, systemic treatments for atopic dermatitis (AD) primarily consisted of immunosuppressive agents such as corticosteroids and Disease Modifying Antirheumatic Drugs (DMARDS), which provided symptomatic relief but often had long-term adverse effects. Newer treatments have shown significant efficacy with less side effects in clinical trials. This review discusses and compares conventional and newer systemic treatments for AD. RECENT FINDINGS: Newer medications for AD including dupilumab, tralokinumab, lebrikizumab, and oral JAK inhibitors have been shown to be safe and efficacious...
April 18, 2024: Current Allergy and Asthma Reports
https://read.qxmd.com/read/38631856/a-case-of-adult-onset-still-s-disease-aosd-with-gastrointestinal-lesions
#10
JOURNAL ARTICLE
Takahito Harada, Yoshikazu Hirata, Hayato Kawamura, Yuki Yamamoto, Yuka Kobayashi, Daisuke Kumai, Akihisa Adachi, Yoshihito Nagura, Hirokazu Ikeuchi, Noriyuki Hayashi, Hiroki Takada, Satoshi Sobue, Megumi Yoshida
A 51-year-old woman with fever was admitted to our hospital. A computed tomography (CT) scan showed thickened colonic walls. Colonoscopy revealed erosion in the ileum and colon. Adult-onset Still's disease (AOSD) was diagnosed due to a subsequent sore throat and skin rash. Following AOSD treatment, methylprednisolone pulse therapy, followed by prednisolone and cyclosporine, was initiated. Despite achieving a temporary improvement, relapse occurred with fever, abdominal pain, with worsening CT and endoscopic findings...
April 16, 2024: Internal Medicine
https://read.qxmd.com/read/38630836/calcineurin-regulates-synaptic-ca-2-permeable-ampa-receptors-in-hypothalamic-presympathetic-neurons-via-%C3%AE-2%C3%AE-1-mediated-glua1-glua2-assembly
#11
JOURNAL ARTICLE
Jing-Jing Zhou, Jian-Ying Shao, Shao-Rui Chen, Hong Chen, Hui-Lin Pan
Hypertension is a major adverse effect of calcineurin inhibitors, such as tacrolimus (FK506) and cyclosporine, used clinically as immunosuppressants. Calcineurin inhibitor-induced hypertension (CIH) is linked to augmented sympathetic output from the hypothalamic paraventricular nucleus (PVN). GluA2-lacking, Ca2+ -permeable AMPA receptors (CP-AMPARs) are a key feature of glutamatergic synaptic plasticity, yet their role in CIH remains elusive. Here, we found that systemic administration of FK506 in rats significantly increased serine phosphorylation of GluA1 and GluA2 in PVN synaptosomes...
April 17, 2024: Journal of Physiology
https://read.qxmd.com/read/38621719/rituximab-or-cyclosporine-a-for-the-treatment-of-membranous-nephropathy-economic-evaluation-of-the-mentor-trial
#12
JOURNAL ARTICLE
Matthew Kadatz, Scott Klarenbach, Helen So, Fernando C Fervenza, Daniel C Cattran, Sean J Barbour
BACKGROUND AND HYPOTHESIS: The MENTOR trial (MEmbranous Nephropathy Trial Of Rituximab) showed that rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria and was superior in maintaining proteinuria remission. However, the cost of rituximab may prohibit first-line use for some patients and health care payers. METHODS: A Markov model was used to determine the incremental cost-effectiveness ratio (ICER) of rituximab compared with cyclosporine for the treatment membranous nephropathy from the perspective of a health care payer with a life-time time horizon...
April 15, 2024: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/38619098/fetal-hemophagocytic-lymphohistiocytosis-with-intravascular-large-b-cell-lymphoma-following-coronavirus-disease-2019-vaccination-in-a-patient-with-systemic-lupus-erythematosus-an-intertwined-case
#13
JOURNAL ARTICLE
Yusuke Ueda, Tomoyuki Sakai, Kazunori Yamada, Kotaro Arita, Yoko Ishige, Daisuke Hoshi, Hiroto Yanagisawa, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Sohsuke Yamada, Akihiro Yachie, Yasufumi Masaki
Hemophagocytic lymphohistiocytosis (HLH) has been recognized as a rare adverse event following the coronavirus disease 2019 (COVID-19) vaccination. We report a case of neuropsychiatric symptoms and refractory HLH in a woman with systemic lupus erythematosus (SLE) after receiving her COVID-19 vaccine treated with belimumab, later found to have intravascular large B-cell lymphoma (IVLBCL) at autopsy. A 61-year-old woman with SLE was referred to our hospital because of impaired consciousness and fever. One month prior to consulting, she received her second COVID-19 vaccine dose...
April 15, 2024: Immunological Medicine
https://read.qxmd.com/read/38618716/inhibition-of-the-mptp-and-lipid-peroxidation-is-additively-protective-against-i-r-injury
#14
JOURNAL ARTICLE
Arielys Mendoza, Pooja Patel, Dexter Robichaux, Daniel Ramirez, Jason Karch
BACKGROUND: During myocardial ischemia/reperfusion (I/R) injury, high levels of matrix Ca2+ and reactive oxygen species (ROS) induce the opening of the mitochondrial permeability transition pore (mPTP), which causes mitochondrial dysfunction and ultimately necrotic death. However, the mechanisms of how these triggers individually or cooperatively open the pore have yet to be determined. METHODS: Here, we use a combination of isolated mitochondrial assays and in vivo I/R surgery in mice...
April 15, 2024: Circulation Research
https://read.qxmd.com/read/38617465/use-of-a-belatacept-based-immunosuppression-for-kidney-transplantation-from-donors-after-circulatory-death-a-paired-kidney-analysis
#15
JOURNAL ARTICLE
Rita Eid, Anne Scemla, Magali Giral, Nadia Arzouk, Dominique Bertrand, Marie-Noëlle Peraldi, Laurent Mesnard, Helene Longuet, Mehdi Maanaoui, Geoffroy Desbuissons, Edouard Lefevre, Renaud Snanoudj
BACKGROUND: Efficacy and safety of belatacept have not been specifically reported for kidney transplantations from donors after circulatory death. METHODS: In this retrospective multicenter paired kidney study, we compared the outcome of kidney transplantations with a belatacept-based to a calcineurin inhibitor (CNI)-based immunosuppression. We included all kidney transplant recipients from donors after uncontrolled or controlled circulatory death performed in our center between February 2015 and October 2020 and treated with belatacept (n = 31)...
May 2024: Transplantation Direct
https://read.qxmd.com/read/38615143/post-transplant-cyclophosphamide-calcineurin-inhibitor-and-mycophenolate-mofetil-compared-to-anti-thymocyte-globulin-calcineurin-inhibitor-and-methotrexate-combinations-as-graft-versus-host-disease-prophylaxis-post-allogeneic-stem-cell-transplantation-from
#16
JOURNAL ARTICLE
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Kulagin, Jakob Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spyridonidis, Eolia Brissot, Fabio Ciceri, Mohamad Mohty
Post-transplant cyclophosphamide plus calcineurin inhibitor (CNI)(tacrolimus or cyclosporine A) plus mycophenolate mofetil (PTCy/TAC or CSA/MMF) and anti-thymocyte globulin plus CNI (tacrolimus or cyclosporine A) plus methotrexate (ATG/TAC or CSA/MTX) are common graft-versus-host disease (GVHD) prophylaxis regimens. We compared the two regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic transplantation from matched siblings or unrelated donors. 402 received PTCy/TAC or CSA/MMF and 5648 received ATG/TAC or CSA/MTX...
April 13, 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38613917/prognostic-model-on-pregnancy-outcomes-for-women-with-recurrent-spontaneous-abortions-treated-with-cyclosporin-a-a-single-institution-experience
#17
JOURNAL ARTICLE
Ze-Ming Zhang, Na Zhang, Xiao-Fei Wang
BACKGROUND: This study aimed to identify prognostic factors for pregnancy outcomes and construct a prognostic model for pregnancy outcomes in women with Recurrent Spontaneous Abortions (RSA) treated with cyclosporin A. METHODS: A total of 154 RSA patients treated with cyclosporin A between October 2016 and October 2018 were retrospectively recruited. Multivariate logistic regression was applied to identify the prognostic factors for pregnancy success in RSA women treated with cyclosporin A...
2024: Clinics
https://read.qxmd.com/read/38613520/ginsenoside-re-protects-against-kainate-induced-neurotoxicity-in-mice-by-attenuating-mitochondrial-dysfunction-through-activation-of-the-signal-transducers-and-activators-of-transcription-3-signaling
#18
JOURNAL ARTICLE
YenNhiDoan Nguyen, JiHoon Jeong, Naveen Sharma, Ngoc KimCuong Tran, Hoang-Yen Phi Tran, Duy-Khanh Dang, JungHoon Park, Jae Kyung Byun, Sung Kwon Ko, Seung-Yeol Nah, Hyoung-Chun Kim, Eun-Joo Shin
It was demonstrated that ginsenosides exert anti-convulsive potentials and interleukin-6 (IL-6) is protective from excitotoxicity induced by kainate (KA), a model of temporal lobe epilepsy. Ginsenosides-mediated mitochondrial recovery is essential for attenuating KA-induced neurotoxicity, however, little is known about the effects of ginsenoside Re (GRe), one of the major ginsenosides. In this study, GRe significantly attenuated KA-induced seizures in mice. KA-induced redox changes were more evident in mitochondrial fraction than in cytosolic fraction in the hippocampus of mice...
April 13, 2024: Free Radical Research
https://read.qxmd.com/read/38607029/oral-antiviral-defense-saliva-and-beverage-like-hypotonicity-dynamically-regulate-formation-of-membraneless-biomolecular-condensates-of-antiviral-human-mxa-in-oral-epithelial-cells
#19
JOURNAL ARTICLE
Pravin B Sehgal, Huijuan Yuan, Anthony Centone, Susan V DiSenso-Browne
The oral mucosa represents a defensive barrier between the external environment and the rest of the body. Oral mucosal cells are constantly bathed in hypotonic saliva (normally one-third tonicity compared to plasma) and are repeatedly exposed to environmental stresses of tonicity, temperature, and pH by the drinks we imbibe (e.g., hypotonic: water, tea, and coffee; hypertonic: assorted fruit juices, and red wines). In the mouth, the broad-spectrum antiviral mediator MxA (a dynamin-family large GTPase) is constitutively expressed in healthy periodontal tissues and induced by Type III interferons (e...
March 28, 2024: Cells
https://read.qxmd.com/read/38606855/calcineurin-inhibitors-experience-in-unplanned-pregnancies-with-active-lupus-disease-a-retrospective-observational-study
#20
JOURNAL ARTICLE
İbrahim Vasi, Derya Yıldırım, Rıza Can Kardaş, Burcugül Kaya, Rahime Duran, Gizem Tuğçe Alp, Hazan Karadeniz, Aslıhan Avanoğlu Güler, Hamit Küçük, Berna Göker, Abdurrahman Tufan, Mehmet Akif Öztürk, Abdulsamet Erden
OBJECTIVES: To evaluate the use of calcineurin inhibitors (CNIs), specifically tacrolimus, in unplanned pregnancies with active lupus disease among patients with systemic lupus erythematosus (SLE). MATERIALS AND METHODS: The study includes data from pregnancies in women diagnosed with SLE at Gazi University Hospital in Ankara, Türkiye, between January 2010 and July 2022. The study categorized pregnancies into planned and unplanned groups based on lupus nephritis presence, emphasizing the need for inactive lupus disease for at least 6 months before attempting conception in planned pregnancies...
April 12, 2024: International Journal of Clinical Pharmacology and Therapeutics
keyword
keyword
42415
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.